全文获取类型
收费全文 | 10904篇 |
免费 | 938篇 |
国内免费 | 46篇 |
专业分类
耳鼻咽喉 | 77篇 |
儿科学 | 345篇 |
妇产科学 | 258篇 |
基础医学 | 1765篇 |
口腔科学 | 89篇 |
临床医学 | 1227篇 |
内科学 | 2341篇 |
皮肤病学 | 256篇 |
神经病学 | 1203篇 |
特种医学 | 279篇 |
外科学 | 1250篇 |
综合类 | 41篇 |
现状与发展 | 1篇 |
一般理论 | 6篇 |
预防医学 | 857篇 |
眼科学 | 210篇 |
药学 | 630篇 |
中国医学 | 11篇 |
肿瘤学 | 1042篇 |
出版年
2024年 | 24篇 |
2023年 | 146篇 |
2022年 | 246篇 |
2021年 | 511篇 |
2020年 | 324篇 |
2019年 | 477篇 |
2018年 | 450篇 |
2017年 | 358篇 |
2016年 | 362篇 |
2015年 | 400篇 |
2014年 | 540篇 |
2013年 | 605篇 |
2012年 | 980篇 |
2011年 | 973篇 |
2010年 | 523篇 |
2009年 | 374篇 |
2008年 | 698篇 |
2007年 | 686篇 |
2006年 | 610篇 |
2005年 | 648篇 |
2004年 | 525篇 |
2003年 | 473篇 |
2002年 | 419篇 |
2001年 | 54篇 |
2000年 | 37篇 |
1999年 | 48篇 |
1998年 | 94篇 |
1997年 | 71篇 |
1996年 | 36篇 |
1995年 | 34篇 |
1994年 | 23篇 |
1993年 | 23篇 |
1992年 | 6篇 |
1991年 | 3篇 |
1990年 | 9篇 |
1989年 | 5篇 |
1988年 | 3篇 |
1987年 | 5篇 |
1986年 | 7篇 |
1985年 | 8篇 |
1984年 | 5篇 |
1983年 | 5篇 |
1982年 | 4篇 |
1981年 | 6篇 |
1980年 | 3篇 |
1978年 | 3篇 |
1934年 | 2篇 |
1933年 | 2篇 |
1932年 | 2篇 |
1928年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
83.
84.
Hesse‐Biber,S. Waiting for Cancer to Come: Women's Experiences with Genetic Testing and Medical Decision Making for Breast and Ovarian Cancer,Michigan: University of Michigan Press. 2014. 216pp $50 (hbk) $24.95 (pbk) $24.95 (ebk) ISBN 978–0‐47205219–6 下载免费PDF全文
Sophie Rees 《Sociology of health & illness》2015,37(7):1124-1125
85.
Kudret Yelden Sophie Duport Leon M. James Agnieszka Kempny Simon F. Farmer Alex P. Leff 《Disability and rehabilitation》2018,40(20):2433-2438
Purpose: To detect any improvement of awareness in prolonged disorders of consciousness in the long term.Methods: A total of 34 patients with prolonged disorders of consciousness (27 vegetative state and seven minimally conscious state; 16 males; aged 21–73) were included in the study. All patients were initially diagnosed with vegetative/minimally conscious state on admission to our specialist neurological rehabilitation unit. Re-assessment was performed 2–16?years later using Coma Recovery Scale-Revised.Results: Although remaining severely disabled, 32% of the patients showed late improvement of awareness evidenced with development of non-reflexive responses such as reproducible command following and localization behaviors. Most of the late recoveries occurred in patients with subarachnoid hemorrhage (5/11, 45.5%). The ages of patients within the late recovery group (Mean?=?45, SD?=?11.4) and non-recovery group (Mean?=?43, SD?=?15.5) were not statistically different (p?=?0.76).Conclusions: This study shows that late improvements in awareness are not exceptional in non-traumatic prolonged disorders of consciousness cases. It highlights the importance of long-term follow up of patients with prolonged disorders of consciousness, regardless of the etiology, age, and time passed since the brain injury. Long-term follow up will help clinicians to identify patients who may benefit from further assessment and rehabilitation. Although only one patient achieved recovery of function, recovery of awareness may have important ethical implications especially where withdrawal of artificial nutrition and hydration is considered.
- Implications for rehabilitation
Long-term regular follow-up of people with prolonged disorders of consciousness is important.
Albeit with poor functional outcomes late recovery of awareness is possible in both traumatic and non-traumatic prolonged disorders of consciousness cases.
Recovery of awareness has significant clinical and ethical implications especially where withdrawal of artificial nutrition and hydration is considered.
86.
87.
88.
Kashyap Patel Julie A Simpson Kevin T Batty Sophie Zaloumis Carl M Kirkpatrick 《British journal of clinical pharmacology》2015,79(1):97-107
Malaria remains a global public health concern and current treatment options are suboptimal in some clinical settings. For effective chemotherapy, antimalarial drug concentrations must be sufficient to remove completely all of the parasites in the infected host. Optimized dosing therefore requires a detailed understanding of the time course of antimalarial response, whilst simultaneously considering the parasite life cycle and host immune elimination. Recently, the World Health Organization (WHO) has recommended the development of mathematical models for understanding better antimalarial drug resistance and management. Other international groups have also suggested that mechanistic pharmacokinetic (PK) and pharmacodynamic (PD) models can support the rationalization of antimalarial dosing strategies. At present, artemisinin-based combination therapy (ACT) is recommended as first line treatment of falciparum malaria for all patient groups. This review summarizes the PK–PD characterization of artemisinin derivatives and other partner drugs from both preclinical studies and human clinical trials. We outline the continuous and discrete time models that have been proposed to describe antimalarial activity on specific stages of the parasite life cycle. The translation of PK–PD predictions from animals to humans is considered, because preclinical studies can provide rich data for detailed mechanism-based modelling. While similar sampling techniques are limited in clinical studies, PK–PD models can be used to optimize the design of experiments to improve estimation of the parameters of interest. Ultimately, we propose that fully developed mechanistic models can simulate and rationalize ACT or other treatment strategies in antimalarial chemotherapy. 相似文献
89.
90.